FINANCIAL STATEMENT 2012: HOCOMA CONTINUES ON ROAD TO SUCCESS
16th July 2013
16th July 2013
Swiss medical technology company expands market leadership in robotic rehabilitation
The medical technology company Hocoma based in Volketswil, Switzerland, reports positive results in the fiscal year 2012. Despite a difficult global economic environment, the Swiss based company was able to present an excellent financial performance and a positive result in all group segments.
Hocoma was set up in 2000, as a spin-off of the Swiss University Hospital Balgrist. The company currently employs more than 150 people at its headquarters near Zurich, Switzerland and at its subsidiaries in the US, Singapore and Slovenia. Hocoma develops and produces therapy solutions for neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, cerebral palsy or other neurological diseases and injuries as well as for low back pain patients. The product range features devices for intensive locomotion therapy (Lokomat®), functional therapy of the upper extremities (Armeo®), early rehabilitation and patient mobilization (Erigo®) as well as functional movement therapy within low back pain treatment (Valedo®). Hocoma’s products are applied successfully in clinics and research institutes worldwide. This medical technology company has received many awards and was honored with the “Red Herring 100 Global Award” in January 2010, as one of the hundred most innovative companies worldwide. Hocoma generated a turnover of more than 30 million CHF in 2012. Dr. Gery Colombo is the CEO of Hocoma AG.